These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms. Zhang X; Li T; Cheng HJ; Wang H; Ferrario CM; Groban L; Cheng CP Life Sci; 2021 Nov; 285():119955. PubMed ID: 34520767 [TBL] [Abstract][Full Text] [Related]
3. Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension. Sun X; Cao J; Chen Z; Liu Y; VonCannon JL; Cheng HJ; Ferrario CM; Cheng CP Heliyon; 2023 Jul; 9(7):e17851. PubMed ID: 37456012 [TBL] [Abstract][Full Text] [Related]
4. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Curran J; Hinton MJ; Ríos E; Bers DM; Shannon TR Circ Res; 2007 Feb; 100(3):391-8. PubMed ID: 17234966 [TBL] [Abstract][Full Text] [Related]
5. CaMKII inhibition in heart failure, beneficial, harmful, or both. Cheng J; Xu L; Lai D; Guilbert A; Lim HJ; Keskanokwong T; Wang Y Am J Physiol Heart Circ Physiol; 2012 Apr; 302(7):H1454-65. PubMed ID: 22287581 [TBL] [Abstract][Full Text] [Related]
6. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Sag CM; Wadsack DP; Khabbazzadeh S; Abesser M; Grefe C; Neumann K; Opiela MK; Backs J; Olson EN; Brown JH; Neef S; Maier SK; Maier LS Circ Heart Fail; 2009 Nov; 2(6):664-75. PubMed ID: 19919992 [TBL] [Abstract][Full Text] [Related]
7. CaMKII inhibition has dual effects on spontaneous Ca Sadredini M; Haugsten Hansen M; Frisk M; Louch WE; Lehnart SE; Sjaastad I; Stokke MK Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H446-H460. PubMed ID: 34270372 [TBL] [Abstract][Full Text] [Related]
8. Calcium/calmodulin-dependent protein kinase II (CaMKII) inhibition ameliorates arrhythmias elicited by junctin ablation under stress conditions. Tzimas C; Terrovitis J; Lehnart SE; Kranias EG; Sanoudou D Heart Rhythm; 2015 Jul; 12(7):1599-610. PubMed ID: 25814413 [TBL] [Abstract][Full Text] [Related]
9. Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Morimoto A; Hasegawa H; Cheng HJ; Little WC; Cheng CP Am J Physiol Heart Circ Physiol; 2004 Jun; 286(6):H2425-33. PubMed ID: 14962832 [TBL] [Abstract][Full Text] [Related]
10. Calmodulin kinase II inhibitor regulates calcium homeostasis changes caused by acute β-adrenergic receptor agonist stimulation in mouse ventricular myocytes. Huang Y; Liu T; Wang D; Wang X; Li R; Chen Y; Tang Y; Wang T; Huang C In Vitro Cell Dev Biol Anim; 2016 Feb; 52(2):156-62. PubMed ID: 26542171 [TBL] [Abstract][Full Text] [Related]
11. Chronic CaMKII inhibition reverses cardiac function and cardiac reserve in HF mice. He Q; Cheng J; Wang Y Life Sci; 2019 Feb; 219():122-128. PubMed ID: 30639281 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of calcium/calmodulin-dependent kinase II restores contraction and relaxation in isolated cardiac muscle from type 2 diabetic rats. Daniels LJ; Wallace RS; Nicholson OM; Wilson GA; McDonald FJ; Jones PP; Baldi JC; Lamberts RR; Erickson JR Cardiovasc Diabetol; 2018 Jun; 17(1):89. PubMed ID: 29903013 [TBL] [Abstract][Full Text] [Related]
13. Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II. Ma Y; Cheng WT; Wu S; Wong TM Br J Pharmacol; 2009 Jul; 157(5):705-15. PubMed ID: 19422373 [TBL] [Abstract][Full Text] [Related]
15. {beta}1-Adrenergic receptor activation induces mouse cardiac myocyte death through both L-type calcium channel-dependent and -independent pathways. Wang W; Zhang H; Gao H; Kubo H; Berretta RM; Chen X; Houser SR Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H322-31. PubMed ID: 20495143 [TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte PKA Ablation Enhances Basal Contractility While Eliminates Cardiac β-Adrenergic Response Without Adverse Effects on the Heart. Zhang Y; Wang WE; Zhang X; Li Y; Chen B; Liu C; Ai X; Zhang X; Tian Y; Zhang C; Tang M; Szeto C; Hua X; Xie M; Zeng C; Wu Y; Zhou L; Zhu W; Yu D; Houser SR; Chen X Circ Res; 2019 Jun; 124(12):1760-1777. PubMed ID: 30982412 [TBL] [Abstract][Full Text] [Related]
17. Death, cardiac dysfunction, and arrhythmias are increased by calmodulin kinase II in calcineurin cardiomyopathy. Khoo MS; Li J; Singh MV; Yang Y; Kannankeril P; Wu Y; Grueter CE; Guan X; Oddis CV; Zhang R; Mendes L; Ni G; Madu EC; Yang J; Bass M; Gomez RJ; Wadzinski BE; Olson EN; Colbran RJ; Anderson ME Circulation; 2006 Sep; 114(13):1352-9. PubMed ID: 16982937 [TBL] [Abstract][Full Text] [Related]
18. CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes. Sag CM; Köhler AC; Anderson ME; Backs J; Maier LS J Mol Cell Cardiol; 2011 Nov; 51(5):749-59. PubMed ID: 21819992 [TBL] [Abstract][Full Text] [Related]
19. CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Di Pasquale E; Lodola F; Miragoli M; Denegri M; Avelino-Cruz JE; Buonocore M; Nakahama H; Portararo P; Bloise R; Napolitano C; Condorelli G; Priori SG Cell Death Dis; 2013 Oct; 4(10):e843. PubMed ID: 24113177 [TBL] [Abstract][Full Text] [Related]
20. Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences. Maltsev VA; Reznikov V; Undrovinas NA; Sabbah HN; Undrovinas A Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1597-608. PubMed ID: 18203851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]